The University of Chicago Header Logo

Wendy Stock

Concepts (889)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Wendy Stock's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Wendy Stock has written about over time.
Myelodysplastic Syndromes, 18 publications between 1993 and 2022, average publication date July 2010. Transplantation Conditioning, 40 publications between 2000 and 2021, average publication date December 2010. Hematologic Neoplasms, 23 publications between 2001 and 2023, average publication date August 2011. Adult, 172 publications between 1981 and 2024, average publication date January 2012. Hematopoietic Stem Cell Transplantation, 59 publications between 1995 and 2023, average publication date May 2012. Humans, 320 publications between 1981 and 2024, average publication date May 2012. Antineoplastic Combined Chemotherapy Protocols, 63 publications between 1995 and 2023, average publication date September 2012. Cytarabine, 23 publications between 2003 and 2023, average publication date September 2013. Philadelphia Chromosome, 17 publications between 1994 and 2022, average publication date December 2013. Neoplasm, Residual, 16 publications between 2000 and 2022, average publication date June 2014. Antineoplastic Agents, 43 publications between 1993 and 2023, average publication date October 2014. Young Adult, 80 publications between 2009 and 2024, average publication date October 2016. Leukemia, Myeloid, Acute, 75 publications between 2004 and 2024, average publication date December 2016. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 89 publications between 1994 and 2024, average publication date February 2017. Azacitidine, 12 publications between 2014 and 2024, average publication date December 2018. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 10 publications between 2014 and 2024, average publication date July 2019. Antineoplastic Agents, Immunological, 8 publications between 2019 and 2022, average publication date May 2020. Asparaginase, 14 publications between 2011 and 2024, average publication date October 2020. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 9 publications between 2015 and 2023, average publication date April 2021.

To see the data from this visualization as text, click here.
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (889)
Explore
_
Co-Authors (82)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_